Group 1 - DigitalBridge (DBRG) shares have increased by 11.8% over the past four weeks, closing at $10.63, with a mean price target of $16.65 indicating a potential upside of 56.6% [1] - The mean estimate consists of 10 short-term price targets with a standard deviation of $2.71, where the lowest estimate is $10.50 (1.2% decline) and the highest is $20 (88.2% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 26.9% over the past month [11][12] Group 2 - The Zacks Rank for DBRG is 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While price targets are often viewed as a key metric, they can mislead investors, and analysts may set overly optimistic targets due to business incentives [7][8] - A low standard deviation in price targets indicates a high degree of agreement among analysts regarding the stock's price movement, serving as a starting point for further research [9]

Shares of Immunome, Inc. (IMNM) have gained 19.1% over the past four weeks to close the last trading session at $9.49, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $24.50 indicates a potential upside of 158.2%.The mean estimate comprises eight short-term price targets with a standard deviation of $5.76. While the lowest estimate of $20 indicates an 110.8% increase from the cu ...

Shares of Quanex Building Products (NX) have gained 7.5% over the past four weeks to close the last trading session at $20.19, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $37 indicates a potential upside of 83.3%.The mean estimate comprises three short-term price targets with a standard deviation of $5.57. While the lowest estimate of $31 indicates a 53.5% increase from the ...

Perrigo (PRGO) closed the last trading session at $27.60, gaining 5.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $36.67 indicates a 32.9% upside potential.The average comprises three short-term price targets ranging from a low of $30 to a high of $42, with a standard deviation of $6.11. While the lowest estimate indicates an increase of 8.7% from the current price level, the ...

Shares of Veris Residential (VRE) have gained 0.2% over the past four weeks to close the last trading session at $15.33, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $19.30 indicates a potential upside of 25.9%.The mean estimate comprises five short-term price targets with a standard deviation of $4.02. While the lowest estimate of $16 indicates a 4.4% increase from the curre ...

Glaukos (GKOS) closed the last trading session at $95.64, gaining 3.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $128.54 indicates a 34.4% upside potential.The average comprises 13 short-term price targets ranging from a low of $72 to a high of $182, with a standard deviation of $33.39. While the lowest estimate indicates a decline of 24.7% from the current price level, the m ...

Core Viewpoint - Byrna Technologies Inc. (BYRN) has seen a 16.8% increase in share price over the past four weeks, closing at $28.79, with a potential upside of 26.8% based on Wall Street analysts' mean price target of $36.50 [1] Group 1: Price Targets and Analyst Estimates - The mean price target consists of three short-term estimates with a standard deviation of $3.12, indicating a range of potential outcomes; the lowest estimate suggests a 14.6% increase to $33, while the highest predicts a 35.5% surge to $39 [2] - Analysts' consensus on earnings estimates has improved, with a positive trend in revisions indicating potential upside for BYRN, as historical data shows a strong correlation between earnings estimate revisions and stock price movements [4][11] - The Zacks Consensus Estimate for the current year has increased by 1.5% due to one upward revision and no negative revisions in the last 30 days, reflecting growing optimism among analysts [12] Group 2: Analyst Behavior and Price Target Reliability - Analysts often set overly optimistic price targets due to business incentives, which can mislead investors; empirical research suggests that price targets rarely indicate actual stock price movements [7][8] - A low standard deviation in price targets indicates a high degree of agreement among analysts regarding the stock's price direction, serving as a starting point for further research into fundamental drivers [9] - While price targets should not be the sole basis for investment decisions, they can provide useful directional guidance when considered alongside other factors [10][13]

Group 1 - FuelCell Energy (FCEL) closed at $6.72, with a 57% gain over the past four weeks, and a mean price target of $9.38 indicating a 39.6% upside potential [1] - The average price targets range from a low of $5 to a high of $13.75, with a standard deviation of $3.19, suggesting variability in analyst estimates [2] - Analysts show strong agreement on FCEL's ability to report better earnings, with positive trends in earnings estimate revisions correlating with potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for FCEL has increased by 0.3% over the past month, indicating a positive outlook with no negative revisions [12] - FCEL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for potential price movements [13]

Sangoma Technologies Corporation (SANG) closed the last trading session at $5.72, gaining 0.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.42 indicates a 47.2% upside potential.The average comprises five short-term price targets ranging from a low of $7.94 to a high of $9.50, with a standard deviation of $0.67. While the lowest estimate indicates an increase of 38.8% from th ...

Group 1 - Alvotech (ALVO) shares have increased by 10.1% over the past four weeks, closing at $10.66, with a mean price target of $18.40 indicating a potential upside of 72.6% [1] - The average price targets range from a low of $14 to a high of $28, with a standard deviation of $5.73, suggesting a variability in estimates; the lowest estimate indicates a 31.3% increase, while the highest points to a 162.7% upside [2] - Analysts show a consensus that Alvotech will report better earnings than previously estimated, which is a positive indicator for potential stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for Alvotech's current year earnings has increased by 251.4% over the last 30 days, with two estimates moving higher and no negative revisions [12] - Alvotech holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [13]